subject area of
- A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus Erythematosus Journal Articles
- A case of mixed hereditary gelsolin amyloidosis and hydroxychloroquine induced myopathy Journal Articles
- A living WHO guideline on drugs to prevent covid-19 Journal Articles
- A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Journal Articles
- A randomized trial of hydroxychloroquine in early rheumatoid arthritis: The HERA study Journal Articles
- A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial Journal Articles
- ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis? Journal Articles
- Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials Journal Articles
- Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI Journal Articles
- Antithrombotic Drugs Journal Articles
- Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. Journal Articles
- COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine Journal Articles
- Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. Journal Articles
- Critical evaluation of platelet-inhibiting drugs in thrombotic disease. Journal Articles
- Drug treatments for covid-19: living systematic review and network meta-analysis Journal Articles
- Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs Journal Articles
- Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19 Journal Articles
- Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis Journal Articles
- Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society Journal Articles
- How trustworthy guidelines can impact outcomes Journal Articles
- Hydroxychloroquine attenuates cigarette smoke induced autophagic signaling in the mouse ovary Journal Articles
-
Hydroxychloroquine for treatment of non‐hospitalized adults with
COVID ‐19: A meta‐analysis of individual participant data of randomized trials Journal Articles - Hydroxychloroquine in Systemic Lupus Erythematosus Journal Articles
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 Journal Articles
- Hydroxychloroquine-Chloroquine, QT-Prolongation, and Major Adverse Cardiac Events: A Meta-analysis and Scoping Review Journal Articles
- Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus Journal Articles
- Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent Journal Articles
- Low-Dose Methotrexate and Serious Adverse Events Among Older Adults With Chronic Kidney Disease Journal Articles
- PLATELET SUPPRESSIVE THERAPY Journal Articles
- Pan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API) Journal Articles
- Platelet inhibitors in the treatment of thrombosis. Journal Articles
- Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease Journal Articles
- Prophylaxis against covid-19: living systematic review and network meta-analysis Journal Articles
- Prophylaxis for COVID-19: a systematic review Journal Articles
- Psoriasis in systemic lupus erythematosus: a single-center experience Journal Articles
- Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. Journal Articles
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results Journal Articles
- Retention of triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine compared to combination methotrexate and leflunomide in rheumatoid arthritis Journal Articles
- Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1) Journal Articles
- Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update Journal Articles
- Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions Journal Articles
- The Current Status of Platelet Suppressive Drugs in the Treatment of Thrombosis Journal Articles
- The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19 Journal Articles
- The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas—a randomized trial Journal Articles
- The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials Journal Articles
- The influence of therapy on CD4+CD25highFOXP3+ regulatory T cells in systemic lupus erythematosus patients: a prospective study Journal Articles
- The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus Journal Articles
- Trials and tribulations: so many potential treatments, so few answers Journal Articles
- What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies? Journal Articles
- Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection? Journal Articles